SANOFI-AVENTIS has a total of 191 patent applications. Its first patent ever was published in 1997. It filed its patents most often in South Africa, Tunisia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SANOFI AVENTIS, ALBERT RAINER and VERTEKS FARMAS JUTIKALZ INKORPOREJTED.
# | Country | Total Patents | |
---|---|---|---|
#1 | South Africa | 75 | |
#2 | Tunisia | 58 | |
#3 | Canada | 23 | |
#4 | Hong Kong | 8 | |
#5 | Taiwan | 7 | |
#6 | Malaysia | 5 | |
#7 | Ukraine | 3 | |
#8 | Argentina | 2 | |
#9 | China | 2 | |
#10 | EAPO (Eurasian Patent Organization) | 2 | |
#11 | Montenegro | 2 | |
#12 | Mexico | 2 | |
#13 | Brazil | 1 | |
#14 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Special acyclic compounds | |
#7 | Analysing materials | |
#8 | Microorganisms | |
#9 | Bioinformatics | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Evanno Yannick | 21 |
#2 | Dubois Laurent | 14 |
#3 | Malanda Andre | 13 |
#4 | Mikol Vincent | 10 |
#5 | Commercon Alain | 9 |
#6 | Vache Julien | 9 |
#7 | Jegham Samir | 8 |
#8 | Casellas Pierre | 8 |
#9 | Czechtizky Werngard | 7 |
#10 | De Peretti Danielle | 7 |
Publication | Filing date | Title |
---|---|---|
EA025017B1 | Method of treating patients with a history of atrial fibrillation or atrial flutter, or current atrial fibrillation or atrial flutter, preventing cardiovascular hospitalization | |
BRPI0816406A2 | use of urate oxidase for the treatment or prophylaxis of indirect heart disorders or sequelae caused by ischemic or reperfusion events. | |
TNSN06218A1 | Derivatives of N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulphonamide, their preparation and their application in therapeutics. |